Search

Your search keyword '"Biotechnology industry -- Licensing, certification and accreditation"' showing total 487 results
Start Over Descriptor "Biotechnology industry -- Licensing, certification and accreditation" Language english
487 results on '"Biotechnology industry -- Licensing, certification and accreditation"'

1. Twist Bioscience awarded LEED certification for Oregon facility

Subjects
Biotechnology industry -- Licensing, certification and accreditation, Green design, Green buildings, Business, News, opinion and commentary, U.S. Green Building Council
Abstract

Twist Bioscience announced that the U.S. Green Building Council, or USGBC, awarded the company's Wilsonville, Oregon facility LEED certification, meeting sustainability standards for its building, operations and [...]

Published
2024

2. Adaptive Biotechnologies announces IVDR certification for clonoSEQ in EU

Subjects
Diagnostic reagents, Biotechnology, Biotechnology industry -- Licensing, certification and accreditation, Business, News, opinion and commentary, European Union
Abstract

Adaptive Biotechnologies announced that clonoSEQ has received In Vitro Diagnostic Regulation 2017/746 Class C certification in the European [...]

Published
2024

3. VaLogic Bio Achieves ISO 9001:2015 Certification, Demonstrating Commitment to Excellence in Biotech and Life Sciences Service

Subjects
Biotechnology, Biotechnology industry -- Licensing, certification and accreditation, Laboratory equipment -- Quality management, Laboratories -- Equipment and supplies, Consulting services -- Licensing, certification and accreditation -- Quality management, Quality control, Quality control, Business, News, opinion and commentary
Abstract

Accomplishment positions VaLogic Bio as a benchmark for quality in its sector FREDERICK, Md., Jan. 9, 2025 /PRNewswire-PRWeb/ -- VaLogic Bio LLC, a trusted partner in providing Calibration, Certification, Validation, [...]

Published
2025

4. Gene Therapy Gives Boy Hope for Life Without Sickle Cell

Author

Kolata, Gina and Holston, Kenny

Subjects
bluebird bio, Inc. -- Licensing, certification and accreditation, Vertex Pharmaceuticals Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Care and treatment, Licensing, certification and accreditation, Methods, Gene therapy -- Methods -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Pharmaceutical industry -- Licensing, certification and accreditation, Sickle cell anemia -- Care and treatment, Biotechnology industry -- Licensing, certification and accreditation
Abstract

After 44 days, Kendric Cromer, 12, left the hospital. While his family feels fortunate that he was the first to receive a treatment, their difficult experiences hint at what others [...]

Published
2024

5. Vizgen Launches Certified Service Provider (CSP) Program, Expanding Access to Single-Cell Spatial Genomics Technology

Subjects
Genetic research, Biotechnology industry -- Licensing, certification and accreditation, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: VIZGEN, INC. has issued the following news release: Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced the official launch [...]

Published
2024

6. Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities

Subjects
Roche Holding AG -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Business, Business, international
Abstract

M2 PRESSWIRE-December 13, 2024-: Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities (C)1994-2024 M2 COMMUNICATIONS RDATE:13122024 * The new cobas [...]

Published
2024

7. Adaptive Announces IVDR Certification for clonoSEQ(R) in European Union

Subjects
Diagnostic reagents -- Laws, regulations and rules, Biotechnology industry -- Licensing, certification and accreditation, Diagnostic equipment (Medical) -- Laws, regulations and rules, Government regulation, Banking, finance and accounting industries, Business, European Union
Abstract

SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]

Published
2024

8. FDA approves Roche's Vabysmo prefilled syringe (PFS) for three leading causes of vision loss

Subjects
United States. Food and Drug Administration -- Powers and duties, Roche Holding AG -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Vision disorders -- Drug therapy, Cartridge drug delivery systems -- Licensing, certification and accreditation, Business, Business, international, Vabysmo (Medication) -- Licensing, certification and accreditation
Abstract

M2 PRESSWIRE-July 8, 2024-: FDA approves Roche's Vabysmo prefilled syringe (PFS) for three leading causes of vision loss (C)1994-2024 M2 COMMUNICATIONS RDATE:06072024 - Vabysmo PFS is the first and only [...]

Published
2024

9. Myriad Genetics Earns 2024 Great Place To Work(R) Certification(TM)

Subjects
Myriad Genetics Inc. -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Job satisfaction, Employees -- Beliefs, opinions and attitudes, Banking, finance and accounting industries, Business
Abstract

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=qg2s7F-j6MVNJJhZY9jaxlqJX9sz5AwsfU0PMLSW47SrzZaAfAJEnDKkdKDPpcUghzZdx9htI3UJ2f4OeqQkWA== (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has received the https://www.globenewswire.com/Tracker?data=Qal0CCF6QZPiuzwEy5FJoRlcU8Cm351UNt28nZiN-u8_oYZs1qtinPwPkVgeVwsQxTwe5_gwpcuotS1LyTcm7_JH_EGSq2vZB1Dl2_-ObhMDgqo-yKG1pkgujs_FkMTd_5xHW4sP0rBZ6O14SLNq2P4zFH80TFH---raemDT1Ac= for the second [...]

Published
2024

10. Anktiva is 'next generation' bladder cancer therapy

Subjects
Anktiva (Medication) -- Licensing, certification and accreditation, Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Immunotherapy -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation
Abstract

CULVER CITY, Calif. -- The Food and Drug Administration has approved ImmunityBio Inc.'s Anktiva (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guerin (BCG) for the treatment of patients with BCG-unresponsive [...]

Published
2024

11. Viralgen receives cGMP certification to produce rAAV commercial grade product at new facility in San Sebastian, Spain

Subjects
Production processes, Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Recombinant molecules -- Production processes, Biotechnology industry -- Licensing, certification and accreditation
Abstract

2023 JAN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Viralgen Vector Core (Viralgen), an independently operated subsidiary of Asklepios BioPharmaceutical, Inc. [...]

Published
2023

12. Enveric Biosciences Announces Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds

Subjects
Drug discovery, Biotechnology industry -- Licensing, certification and accreditation, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, announces that it has signed three [...]

Published
2024

13. New covid booster can update protection from severe disease, Western Pa. doctors say

Author

Maruca, Julia

Subjects
United States. Food and Drug Administration -- Powers and duties, Pfizer Inc. -- Licensing, certification and accreditation, Moderna Inc. -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Drug approval, Pharmaceutical industry -- Licensing, certification and accreditation, General interest, News, opinion and commentary
Abstract

Byline: Julia Maruca Sep. 13Western Pennsylvania doctors say the newly approved covid booster vaccine will help protect from severe impacts of the most recent variants. The U.S. Food and Drug [...]

Published
2023

14. MedGenome achieves 10x Genomics Certified Service provider qualification for single cell sequencing

Subjects
Genetic research, Biotechnology industry -- Licensing, certification and accreditation, Business, News, opinion and commentary
Abstract

FOSTER CITY, Calif., Nov. 7, 2023 /PRNewswire/ -- https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fresearch.medgenome.com&esheet=53377132&newsitemid=20230410005069&lan=en-US&anchor=MedGenome&index=1&md5=73e3878657f12751d1703228b20312ad, a global precision medicine company specializing in omics solutions, announced today that it has achieved the 10x Genomics Certified Service Provider [...]

Published
2023

15. Overdose drug Narcan gets OTC approval

Author

Alltucker, Ken

Subjects
United States. Food and Drug Administration -- Powers and duties, Emergent BioSolutions Inc. -- Licensing, certification and accreditation, Drugs -- Overdose, Nonprescription drugs -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Naloxone -- Licensing, certification and accreditation, News, opinion and commentary, Narcan (Medication) -- Licensing, certification and accreditation
Abstract

Byline: Ken Alltucker, USA TODAY The Food and Drug Administration on Wednesday approved selling the overdose-reversal drug Narcan without a prescription, a move long sought by advocates to improve access [...]

Published
2023

16. Myriad Genetics, Inc. achieves 2023 Great Place to Work certification

Subjects
Myriad Genetics Inc. -- Licensing, certification and accreditation, Work environment, Biotechnology industry -- Licensing, certification and accreditation, General interest, News, opinion and commentary
Abstract

SALT LAKE CITY: Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced it has achieved the Great Place to Work certification for 2023. The certification is based [...]

Published
2023

17. Myriad Genetics and Intermountain Precision Genomics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification

Subjects
Myriad Genetics Inc. -- Licensing, certification and accreditation, Tumors, Biotechnology industry -- Licensing, certification and accreditation, Medical laboratories, General interest, News, opinion and commentary
Abstract

SALT LAKE CITY: Myriad Genetics, Inc. has issued the following news release: Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, a [...]

Published
2023

18. FDA advisors recommend the Novavax COVID vaccine

Subjects
Novavax Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Licensing, certification and accreditation, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=1103652973 BYLINE: ROB STEIN HOST: STEVE INSKEEP STEVE INSKEEP: The United States is close to approving another COVID-19 vaccine. A Food and Drug [...]

Published
2022

19. FDA authorizes Novavax coronavirus booster shot

Author

McGinley, Laurie

Subjects
Novavax Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Licensing, certification and accreditation, Laws, regulations and rules, Government regulation, RNA vaccines -- Licensing, certification and accreditation, COVID-19 vaccines -- Licensing, certification and accreditation, Secondary immunization -- Laws, regulations and rules, Biotechnology industries -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation
Published
2022

20. Nucleus Biologics Receives Int'l Certification: BIOTECH: Company Innovating Cell Culture Media Industry

Author

Clemetson, Jeff

Subjects
Biotechnology, Biotechnology industry -- Licensing, certification and accreditation, Quality control, Quality control, Business, Business, regional, International Organization for Standardization
Abstract

Nucleus Biologies has received a stamp of approval for its custom cell culture media for the gene and cell therapy industry. On Aug. 23, the company announced it had been [...]

Published
2022

21. GoodWheat Pasta Receives American Heart Association(r) Heart-Check Certification

Subjects
Arcadia Biosciences Inc. -- Licensing, certification and accreditation, Societies, Biotechnology industry -- Licensing, certification and accreditation, Natural foods, Nutrition -- Requirements, Associations, institutions, etc., General interest, News, opinion and commentary
Abstract

DAVIS: Arcadia Biosciences, Inc. has issued the following news release: GoodWheat pasta is breaking new ground in helping consumers make healthier food choices by receiving the American Heart Association's Heart-Check [...]

Published
2023

22. GoodWheat(TM) Pasta Receives American Heart Association Heart-Check Certification

Subjects
Arcadia Biosciences Inc. -- Licensing, certification and accreditation, Societies, Biotechnology industry -- Licensing, certification and accreditation, Natural foods, Nutrition -- Requirements, Associations, institutions, etc., Business, News, opinion and commentary
Abstract

-- Single ingredient pasta provides four times the fiber of traditional pasta with no sacrifice on taste -- DAVIS, Calif., Jan. 18, 2023 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3759702-1&h=2024444433&u=https%3A%2F%2Featgoodwheat.com%2F&a=GoodWheat%E2%84%A2 pasta is breaking new [...]

Published
2023

23. COVID-19 vaccines for youngest children clear first government hurdle

Author

Weintraub, Karen

Subjects
United States. Food and Drug Administration -- Powers and duties, United States. Centers for Disease Control and Prevention -- Powers and duties, BioNTech SE -- Licensing, certification and accreditation, Pfizer Inc. -- Licensing, certification and accreditation, Moderna Inc. -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Children -- Health aspects, Pharmaceutical industry -- Licensing, certification and accreditation, News, opinion and commentary
Abstract

Byline: Karen Weintraub, USA TODAY America's youngest children soon could have access to two COVID-19 vaccines. An expert panel on Wednesday unanimously found Moderna's vaccine safe for children 6 months [...]

Published
2022

24. FDA advisers recommend greenlighting coronavirus vaccines for young kids

Author

McGinley, Laurie, Abutaleb, Yasmeen, and Shepherd, Katie

Subjects
BioNTech SE -- Licensing, certification and accreditation, Pfizer Inc. -- Licensing, certification and accreditation, Moderna Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Licensing, certification and accreditation, COVID-19 vaccines -- Licensing, certification and accreditation, Child health, Biotechnology industries -- Licensing, certification and accreditation, Pharmaceutical industry -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Children -- Health aspects
Published
2022

25. Moderna seeking FDA authorization of omicron-specific booster shot

Author

Abutaleb, Yasmeen and Jeong, Andrew

Subjects
Moderna Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Planning, Licensing, certification and accreditation, Company business planning, COVID-19 vaccines -- Licensing, certification and accreditation, Secondary immunization -- Planning, Biotechnology industries -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation
Published
2022

26. Pfizer seeks authorization of a coronavirus shot for children under 5

Author

Johnson, Carolyn Y.

Subjects
BioNTech SE -- Licensing, certification and accreditation, Pfizer Inc. -- Licensing, certification and accreditation, Comirnaty (Vaccine) -- Youth market -- Licensing, certification and accreditation, Youth market, Licensing, certification and accreditation, COVID-19 vaccines -- Licensing, certification and accreditation -- Youth market, Child health, Biotechnology industries -- Licensing, certification and accreditation, Pharmaceutical industry -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Children -- Health aspects
Published
2022

27. Pfizer seeks authorization of a coronavirus shot for children under 5

Author

Johnson, Carolyn Y.

Subjects
BioNTech SE -- Licensing, certification and accreditation, Pfizer Inc. -- Licensing, certification and accreditation, Comirnaty (Vaccine) -- Youth market -- Licensing, certification and accreditation, Youth market, Licensing, certification and accreditation, COVID-19 vaccines -- Licensing, certification and accreditation -- Youth market, Child health, Biotechnology industries -- Licensing, certification and accreditation, Pharmaceutical industry -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Children -- Health aspects
Published
2022

28. CDC panel OKs 3rd Pfizer shot for kids 5-11

Author

Weise, Elizabeth

Subjects
United States. Centers for Disease Control and Prevention -- Powers and duties, BioNTech SE -- Licensing, certification and accreditation, Pfizer Inc. -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Children -- Health aspects, Pharmaceutical industry -- Licensing, certification and accreditation, Government regulation, News, opinion and commentary
Abstract

Byline: Elizabeth Weise, USA TODAY A Centers for Disease Control and Prevention scientific advisory committee voted Thursday to recommend a third dose of the Pfizer-BioNTech vaccine for children aged 5 [...]

Published
2022

29. FDA authorizes a coronavirus booster shot for children as young as 5

Author

Johnson, Carolyn Y. and McGinley, Laurie

Subjects
BioNTech SE -- Licensing, certification and accreditation, Pfizer Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Licensing, certification and accreditation, COVID-19 vaccines -- Licensing, certification and accreditation, Child health, Secondary immunization -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Pharmaceutical industry -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Children -- Health aspects
Published
2022

30. Moderna seeks OK for kids' vaccine

Author

Rodriguez, Adrianna

Subjects
Moderna Inc. -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Children -- Health aspects, News, opinion and commentary, Spikevax (Vaccine) -- Licensing, certification and accreditation -- Usage
Abstract

Byline: Adrianna Rodriguez, USA TODAY Moderna has submitted a request for emergency use authorization for its COVID-19 vaccine for children 6 months through 5 years old, the company announced Thursday [...]

Published
2022

31. Moderna will seek OK for Canadian COVID-19 vaccines for kids under 6

Author

Morgan, Linda

Subjects
Moderna Inc. -- Licensing, certification and accreditation, Canada. Health Canada -- Powers and duties, Spikevax (Vaccine) -- Dosage and administration -- Licensing, certification and accreditation -- Demographic aspects, Powers and duties, Demographic aspects, Dosage and administration, Licensing, certification and accreditation, Laws, regulations and rules, Government regulation, COVID-19 vaccines -- Dosage and administration -- Licensing, certification and accreditation -- Demographic aspects, Child health, Biotechnology industries -- Licensing, certification and accreditation, Vaccination -- Laws, regulations and rules -- Demographic aspects, Biotechnology industry -- Licensing, certification and accreditation, Children -- Health aspects
Published
2022

32. Akoya Biosciences Gets ISO 13485:2016 Quality Certification

Subjects
Biotechnology industry -- Licensing, certification and accreditation, Arts and entertainment industries
Abstract

Akoya Biosciences reported that the company received ISO 13485:2016 certification for the design, development, production, distribution and installation of medical devices and related services. According to a media release, achieving [...]

Published
2020

33. (WTRC) Notification on Corporate Action 'Withholding Tax Relief Certification' - AMGEN INC. 3.2 02|11|27 (bonds ISIN US031162CQ15)

Subjects
Amgen Inc. -- Licensing, certification and accreditation -- Taxation, Biotechnology industry -- Licensing, certification and accreditation, Taxation, Business, international
Abstract

Moscow: National Settlement Depository (Moscow Exchange Group) has issued the following news release: Corporate Action Information Corporate Action Reference 749997 Corporate Action Type Code WTRC Corporate Action Type Withholding Tax [...]

Published
2022

34. APCER Life Sciences Awarded ISO 9001:2015 Certification: Validating its Unwavering Commitment to Excellence in Quality

Subjects
United Kingdom Accreditation Service -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Quality control, Quality control, General interest, News, opinion and commentary
Abstract

NEW DELHI: APCER Life Sciences has issued the following news release: APCER Life Sciences, the preferred services provider for Pharmaceutical and Biotech companies looking for compliance solutions across the drug [...]

Published
2022

35. APCER Life Sciences Awarded ISO 9001:2015 Certification: Validating its Unwavering Commitment to Excellence in Quality

Subjects
United Kingdom Accreditation Service -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Quality control, Quality control, Business, Business, international
Abstract

Assures a robust quality management system to its customers NEW DELHI -- APCER Life Sciences, the preferred services provider for Pharmaceutical and Biotech companies looking for compliance solutions across the [...]

Published
2022

36. Twist Bioscience Earns 2022 Great Place to Work Certification

Subjects
Employers, Employee retention, Biotechnology industry -- Licensing, certification and accreditation, Corporate culture, General interest, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO: Twist Bioscience Corporation has issued the following news release: Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA [...]

Published
2022

37. Twist Bioscience Earns 2022 Great Place to Work Certification

Subjects
Employers, Employee retention, Biotechnology industry -- Licensing, certification and accreditation, Corporate culture, Business, Business, international
Abstract

SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that [...]

Published
2022

38. European Union Authorizes Covid Vaccine From Novavax, a U.S. Company

Author

Zimmer, Carl

Subjects
Novavax Inc. -- Licensing, certification and accreditation, European Union. European Commission -- Powers and duties, Nuvaxovid (Vaccine) -- Licensing, certification and accreditation, Powers and duties, Licensing, certification and accreditation, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation
Abstract

The vaccine will be the fifth to become available in the E.U., which already has ample supplies. The European Commission on Monday authorized a Covid-19 vaccine made by Novavax, making [...]

Published
2021

39. Pfizer, BioNTech seek approval for vaccine booster

Subjects
BioNTech SE -- Licensing, certification and accreditation, Pfizer Inc. -- Licensing, certification and accreditation, Comirnaty (Vaccine) -- Licensing, certification and accreditation -- Dosage and administration, Licensing, certification and accreditation, Dosage and administration, COVID-19 vaccines -- Dosage and administration -- Licensing, certification and accreditation, Secondary immunization -- Licensing, certification and accreditation -- Dosage and administration, Biotechnology industries -- Licensing, certification and accreditation, Pharmaceutical industry -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation
Abstract

NEW YORK -- Pfizer Inc. and BioNTech SE last month filed a supplemental Biologies License Application (sBLA) with the Food and Drug Administration for the approval of a booster (third) [...]

Published
2021

40. (WTRC) Notification on Corporate Action 'Withholding Tax Relief Certification' - AMGEN INC. 3.2 02|11|27 (bonds ISIN US03162CQ15)

Subjects
Amgen Inc. -- Licensing, certification and accreditation -- Taxation, Biotechnology industry -- Licensing, certification and accreditation, Taxation, Business, international
Abstract

Moscow: National Settlement Depository (Moscow Exchange Group) has issued the following news release: Corporate Action Information Corporate Action Reference 697969 Corporate Action Type Code WTRC Corporate Action Type Withholding Tax [...]

Published
2022

41. (WTRC) Notification on Corporate Action 'Withholding Tax Relief Certification' - AMGEN INC. 8.125 01|04|97 (bonds ISIN US031162AA80)

Subjects
Amgen Inc. -- Licensing, certification and accreditation -- Taxation, Biotechnology industry -- Licensing, certification and accreditation, Taxation, Business, international
Abstract

Moscow: National Settlement Depository (Moscow Exchange Group) has issued the following news release: Corporate Action Information Corporate Action Reference 690231 Corporate Action Type Code WTRC Corporate Action Type Withholding Tax [...]

Published
2022

42. FDA Gives OK To 2nd Coronavirus Vaccine Distribution

Subjects
Moderna Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Spikevax (Vaccine) -- Licensing, certification and accreditation, Powers and duties, Licensing, certification and accreditation, Laws, regulations and rules, Government regulation, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Drug approval -- Laws, regulations and rules, Biotechnology industry -- Licensing, certification and accreditation
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=948403387 BYLINE: SELENA SIMMONS-DUFFIN HOST: MICHEL MARTIN MICHEL MARTIN: Thousands of boxes are being packed up and loaded today filled with the second [...]

Published
2020

43. News Brief: Moderna Vaccine, Russian Hack, Coronavirus Relief Bill

Subjects
Moderna Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Economic aspects, Political aspects, Licensing, certification and accreditation, Laws, regulations and rules, Forecasts and trends, Government regulation, Market trend/market analysis, Computer crime, Computer crimes -- Forecasts and trends -- Political aspects, Epidemics -- Forecasts and trends -- Economic aspects -- United States, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Domestic economic assistance -- Laws, regulations and rules -- Political aspects, National security -- Forecasts and trends -- Laws, regulations and rules, Drug approval -- Laws, regulations and rules, Biotechnology industry -- Licensing, certification and accreditation
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=947918235 BYLINE: JOE PALCA HOST: STEVE INSKEEP STEVE INSKEEP: So many people need protection so quickly from coronavirus that it's considered essential to [...]

Published
2020

44. Moderna's COVID-19 Vaccine Await's Emergency Authorization From FDA

Subjects
Moderna Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Licensing, certification and accreditation, Laws, regulations and rules, Government regulation, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Drug approval -- Laws, regulations and rules, Biotechnology industry -- Licensing, certification and accreditation
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=947940391 BYLINE: JOE PALCA HOST: STEVE INSKEEP STEVE INSKEEP: We started this week with the Pfizer vaccine arriving at sites across the United [...]

Published
2020

45. FDA Immunization Panel Assesses Moderna's Application For Its COVID-19 Vaccine

Subjects
Moderna Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Licensing, certification and accreditation, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=947693769 BYLINE: JOE PALCA HOST: AILSA CHANG AILSA CHANG: An independent panel of experts met today to help the Food and Drug Administration [...]

Published
2020

46. News Brief: Moderna Vaccine, Pandemic Economy, Google Monopoly Suit

Subjects
Moderna Inc. -- Licensing, certification and accreditation, Google L.L.C. -- Cases, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Economic aspects, Cases, Licensing, certification and accreditation, Laws, regulations and rules, Forecasts and trends, Company legal issue, Government regulation, Internet/Web advertising, Market trend/market analysis, Internet service provider, Epidemics -- Forecasts and trends -- Economic aspects -- United States, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Internet service providers -- Cases, Monopolies -- Cases, Drug approval -- Laws, regulations and rules, Cabinet officials -- Powers and duties, Economic growth -- Forecasts and trends, Internet advertising -- Cases, Internet/Web advertising -- Cases, Biotechnology industry -- Licensing, certification and accreditation, Cabinet officers -- Powers and duties
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=947440017 BYLINE: JOE PALCA HOST: RACHEL MARTIN RACHEL MARTIN: A second COVID-19 vaccine may soon get cleared for use. STEVE INSKEEP: The maker, [...]

Published
2020

47. Independent Panel To Give FDA Its Opinion On Moderna COVID-19 Vaccine

Subjects
Moderna Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Care and treatment, Licensing, certification and accreditation, Laws, regulations and rules, Forecasts and trends, Government regulation, Market trend/market analysis, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Drug approval -- Laws, regulations and rules, COVID-19 -- Forecasts and trends -- Care and treatment, Biotechnology industry -- Licensing, certification and accreditation
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=947440062 BYLINE: JOE PALCA HOST: STEVE INSKEEP STEVE INSKEEP: Today, an independent advisory panel gives its judgment of a coronavirus vaccine. It's one [...]

Published
2020

48. Analysis By FDA Of Moderna's COVID-19 Vaccine Finds It Effective, Safe

Subjects
Moderna Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Spikevax (Vaccine) -- Licensing, certification and accreditation, Powers and duties, Licensing, certification and accreditation, Laws, regulations and rules, Government regulation, COVID-19 vaccines -- Licensing, certification and accreditation, Biotechnology industries -- Licensing, certification and accreditation, Drug approval -- Laws, regulations and rules, Biotechnology industry -- Licensing, certification and accreditation
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=946654076 BYLINE: JOE PALCA HOST: STEVE INSKEEP STEVE INSKEEP: OK. Let's review a few things that Dr. Fauci just said. He said the [...]

Published
2020

49. Seattle Genetics Completes Enrollment in Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer

Subjects
United States. Food and Drug Administration -- Powers and duties, Seagen Inc. -- Licensing, certification and accreditation, Biotechnology industry -- Licensing, certification and accreditation, Drug approval, Clinical trials -- Licensing, certification and accreditation, Arts and entertainment industries
Abstract

Seattle Genetics reported completion of enrollment in the potentially pivotal innovaTV 204 phase 2 clinical trial evaluating the efficacy, safety and tolerability of tisotumab vedotin as monotherapy for patients with [...]

Published
2019

50. EDGC, the First International Standard for Information Protection in the Genome Industry - Simultaneous Acquisition of ISO 27001 and ISO 27799

Subjects
Genetic research -- Standards, Biotechnology industry -- Licensing, certification and accreditation, Business, Business, international, International Organization for Standardization -- Standards
Abstract

M2 PRESSWIRE-March 28, 2022-: EDGC, the First International Standard for Information Protection in the Genome Industry - Simultaneous Acquisition of ISO 27001 and ISO 27799 (C)1994-2022 M2 COMMUNICATIONS RDATE:25032022 Eone [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results